Refractory Celiac Disease News and Research

RSS

Coeliac UK and Innovate UK announce £180k research funding

Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK’s innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.

6 Jun 2019

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet.

22 May 2018

Researchers develop model to predict mortality risk for celiac disease patients

An international research team led by Mayo Clinic has developed a first-of-its-kind model to predict mortality in patients suffering from celiac disease (CD).

9 Aug 2016

Celimmune to provide oral presentation on AMG 714 antibody at 16th International Coeliac Disease Symposium

Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that Dr. Francisco Leon, CEO and Chief Medical Officer, will provide an oral presentation on an abstract related to the company's lead product candidate, AMG 714, at the 16th International Coeliac Disease Symposium, June 24, 2015, in Prague, Czech Republic.

22 Jun 2015

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that it has licensed a Phase 2-stage, anti-IL-15 monoclonal antibody (AMG 714) from Amgen.

2 Mar 2015

International symposium to focus on celiac disease and gluten-related disorders

Preliminary results from a multinational project to study the impact of early childhood nutrition on celiac disease will be among the highlights of this month's 15th International Celiac Disease Symposium, hosted by the University of Chicago Medicine Celiac Disease Center.

23 Sep 2013

Refractory Celiac Disease News and Research

Coeliac UK and Innovate UK announce £180k research funding

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

Researchers develop model to predict mortality risk for celiac disease patients

Celimmune to provide oral presentation on AMG 714 antibody at 16th International Coeliac Disease Symposium

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

International symposium to focus on celiac disease and gluten-related disorders

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Natural products: the next frontier in drug discovery

Latest News